A Randomized, Double-Blind Study to Compare the Durability of Glucose Lowering and Preservation of Pancreatic Beta-Cell Function of Rosiglitazone Monotherapy Compared to Metformin or Glyburide/Glibenclamide in Patients With Drug-Naive, Recently Diagnosed Type 2 Diabetes Mellitus
A Randomized, Double-Blind Study to Compare the Durability of Glucose Lowering and Preservation of Pancreatic Beta-Cell Function of Rosiglitazone Monotherapy Compared to Metformin or Glyburide/Glibenclamide in Patients With Drug-Naive, Recently Diagnosed Type 2 Diabetes Mellitus
The study will compare and evaluate the effects of long-term treatment of monotherapy with rosiglitazone, metformin and glyburide/glibenclamide on the improvement and maintenance of glycemic control in patients with recently diagnosed type 2 diabetes mellitus.
Inclusion criteria:
Exclusion criteria:
Cambellton, New Brunswick E3N 3S8, Canada
St-Isidore de Dorchester, Quebec G0S 2S0, Canada
Phaha 5, 150 06, Czechia
Frederiksberg C, 1900, Denmark
Lmatra, 55800, Finland
Alben, 73410, France
Bezier, 34500, France
Brogile, 27270, France
Mont de Marsen, 40000, France
Roanna, 42300, France
Saint Genies Des Fontaines, 66740, France
Krummenaab, Bavaria 92703, Germany
Bad Kreuznach, Hesse 55545, Germany
Paderborn, Lower Saxony 33100, Germany
Winsen/Lohe, Lower Saxony 21423, Germany
Schwabenheim, North Rhine-Westphalia 55270, Germany
Belfast, BT16 ORH, Ireland
Co. Tipperary, Ireland
S. Benedetto TR (AP), Italy
San Giovanni Rotondo FG, Italy
Basurto/Bilbao, 48013, Spain
Elda-Alicante, 03600, Spain
Olleria, Valencia, 46850, Spain
Onda/Castellón, 12200, Spain
Sagunto/Valencia, 46520, Spain
San Vincente Raspeig (Alicante), 03690, Spain
Santa Coloma de Gramanet (Barcelona), 08923, Spain
Tereul, 44002, Spain
Torrelavega/Santander, 39300, Spain
Vallda (Valencia), Spain
Villajoyosa - Alicante, 03570, Spain
Degerberga, 297 31, Sweden
Co.Antrim, United Kingdom